全球皮下注射裝置市場(至 2028 年)

本報告分析了全球皮下注射裝置市場，包括市場基本結構和最新情況、主要促進/制約因素、整體市場規模趨勢預測(至2028年)，我們將為您提供主要治療領域(共9種)的詳細趨勢，主要公司的概況和業務發展狀況，以及主要業務合作和聯盟的動向。

目錄

執行摘要

• 皮下自行給藥注射裝置
• 執行摘要
• 市場機會
• 配送市場動態
• 注射經濟學
• 注射裝置的促生長因子
• 預充式註射器快速增長
• 自我管理趨勢
• 人口變化
• 一次性設備設計創新
• 增加生物製藥
• 治療性單克隆抗體
• 推動治療需求的因素
• 競爭形勢
• 風險因素
• 自動注射器：商用設備
• 手動注射器
• 自動注射器
• 一次性自動注射器
• Molly (SHL 醫療)
• Molly RNS (SHLMedical)
• Bertha (SHL 醫療)
• Maggie (SHL 醫療)
• Amber (SHL 醫療)
• SafeLock (SHL 醫療)
• VSDI + NIT (SHL 醫療)
• SDI MIX + NIT (SHL Medical)
• Syrina S (Consort Medical)
• Syrina AS (Consort Medical)
• AutoJect 2(歐文芒福德)
• SelfDose(西藥服務)
• Flexi-Q PFS(愛康醫療)
• OTS 自動注射器(Consort Medical)
• 項目 (Aptar)
• Consort Medical ASI
• Ypsomed VarioJect
• Rotaject 技術(SHL 醫療)
• Viscala 自動注射器(Consort Medical)
• Flexi-Q HV(愛康醫療)
• Intevia (Becton Dickinson)
• Antares Pharma 自動注射器
• 大理醫療器械
• 開發階段的自動注射器
• NIS 自動注射器(Midas Pharma)
• ArQ-(橢圓形醫療)
• 無線啟用自動注射器
• BETA CONNECT(拜耳)
• RebiSmart (默克雪蘭諾)
• 自動注射器：主要產品規格
• Arsma/舒馬曲坦自動注射器
• 舒馬曲坦(雷迪博士的)
• Rebif/Rebidose (默克雪蘭諾)
• Aimovig (安進/諾華)
• Enbrel Mini AutoTouch (安進)
• Pegasys Proclick(基因泰克/羅氏)
• Otrexup (Antares Pharma)
• Evzio (Kaleo)
• 自動注射器的設計元素
• 材料選擇問題
• 零件數量和設備成本
• 安全功能
• 進針深度
• 故障安全激活
• 劑量測試/注射確認
• 凍乾藥/重建
• 人體工學/人體工學
• 筆式註射器
• 筆式註射器設計選擇因素
• 標準筆台
• 哈塞爾邁爾
• 流式細胞儀狄金森
• 歐文芒福德
• Autoject2
• Ypsomed
• SHL 醫療
• 定製筆設計
• 可重複使用的筆
• 兩室筆
• 實用筆產品
• 促性腺激素筆
• Humatro-Pen/Humatro Pen 3
• 去甲腎上腺素
• NordiPenmate
• Nutropin AQ 筆
• 萬能的
• 一鍵式
• 來得時/Toujeo(甘精胰島素)
• 迪亞彭
• 甘肅林筆
• Flexpen(諾和諾德)
• Humalog Pen/Kwik Pen
• HumaPen 回憶錄
• HumaPen Luxura HD
• NovoPen(諾和諾德)
• 獨奏星
• Byetta 筆
• Bydureon
• Symlin 筆
• 薩克森達
• Tanzeum(阿布裡魯□)
• 真誠
• 維克托薩
• 甲狀旁腺激素
• Forteo筆
• Preotact/Preos
• 納帕拉
• 生殖激素
• Follistim/Puregon Pen
• Gonal-f
• 可穿戴設備：產品分析與評估
• Libertas (Becton Dickinson)
• 貼片泵(Sensile Medical)
• SmartDose(西藥)
• Neulasta OnPro 注射器(胰島素/安進)
• YpsoDose (Ypsomed)
• 電子半一次性
• E3D 貼片泵 (Elcam)
• 一次性機械零件
• enFuse(啟用注入)
• 強制設備
• sc2Wear 輸液器 (scPharmaceuticals)
• 補丁泵 (SteadyMed)
• 無線數據
• 主要治療藥物：分領域分析
• 過敏反應/對策
• 自身免疫性疾病
• 類風濕性關節炎
• 牛皮癬
• 多發性硬化症
• 艾塞那□ (Byetta)
• Bydureon
• 普蘭立□ (Symlin)
• Abliglutide (Tanzeum)
• 肝炎
• 激素
• 骨質疏鬆症
• 市場因素
• 監管問題
• 設備品牌
• 患者依從性和易用性
• 衛生經濟學
• 公司簡介

Evolution in Therapeutic Care

Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver. For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.

What You Will Learn:

• Provides detailed analysis of subcutaneous drug products, drug delivery and device strategies, and product development factors

• Assesses key markets, market dynamics and market demographics

• Analyzes therapeutic demand drivers and evaluates SC drug products in nine key therapeutic segments

• Provides market data and forecasts to 2028

• Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations

• Assesses the importance of alliances and partnerships on subcutaneous drug product commercialization

• Evaluates the impact of economic, technology, and regulatory factor

Table of Contents

Executive Summary

• Injection Devices for Subcutaneous Self-administration
• Executive Summary
• The Market Opportunity
• Delivery Market Dynamics
• The Economics of Injectable Drugs
• What's Driving the Growth in Injectable Devices?
• Prefilled Syringes Proliferating
• The Trend toward Self-Administration
• Shifting Demographics
• Innovation in Disposable Device Designs
• Proliferation of Biological Drugs
• Therapeutic Monoclonal Antibodies
• Therapeutic Demand Drivers
• Competitive Landscape
• Risk Factors
• Autoinjectors - Commercial Devices
• Manual Injection Autoinjectors
• Automated Injection Autoinjectors
• Disposable Autoinjectors
• Molly (SHL Medical)
• Molly RNS (SHLMedical)
• Bertha (SHL Medical)
• Maggie (SHL Medical)
• Amber (SHL Medical)
• SafeLock (SHL Medical)
• VSDI +NIT (SHL Medical)
• SDI MIX +NIT (SHL Medical)
• Syrina S (Consort Medical)
• Syrina AS (Consort Medical)
• AutoJect 2 (Owen Mumford)
• SelfDose (West Pharmaceutical Services)
• Flexi-Q PFS (Elcam Medical)
• OTS Autoinjector (Consort Medical)
• Pro-Ject (Aptar)
• Consort Medical ASI
• Ypsomed VarioJect
• Rotaject Technology (SHL Medical)
• Viscala Autoinjector (Consort Medical)
• Flexi-Q HV (Elcam Medical)
• Intevia (Becton Dickinson)
• Antares Pharma Autoinjectors
• Dali Medical Devices
• Development-stage Autoinjectors
• NIS Autoinjector (Midas Pharma)
• ArQ - (Oval Medical)
• Wirelessly Enabled Autoinjectors
• BETACONNECT (Bayer)
• RebiSmart (Merck Serono)
• Selected Product Specific Autoinjectors
• Alsuma/Sumatriptan Autoinjector
• Sumatriptan (Dr. Reddy's)
• Rebif/Rebidose (Merck Serono)
• Aimovig (Amgen/Novartis)
• Enbrel Mini AutoTouch (Amgen)
• Pegasys Proclick (Genentech/Roche)
• Otrexup (Antares Pharma)
• Evzio (Kaleo)
• Autoinjector Device Design Factors
• Material Selection Issues
• Part Counts and Device Cost
• Safety Features
• Needle Insertion Depth
• Failsafe Activation
• Dose Inspection/Injection Confirmation
• Lyophilized Drugs/Reconstitution
• Human Engineering/Ergonomics
• Pen Injectors
• Pen Injector Design Selection Factors
• Standardized Pen Platforms
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Autoject2
• Ypsomed
• SHL Medical
• Custom Pen Designs
• Reusable Pens
• Dual Chamber Pens
• Commercial Pen Products
• Genotropin Pen
• Humatro-Pen/Humatro Pen 3
• Norditropin
• NordiPenmate
• Nutropin AQ Pen
• Omnitrope
• One.Click
• Lantus/Toujeo (Insulin Glargine)
• Diapen
• Gansulin Pen
• Flexpen (Novo Nordisk)
• Humalog Pen/KwikPen
• HumaPen Memoir
• HumaPen Luxura HD
• NovoPen (Novo Nordisk)
• SoloStar
• Byetta Pen
• Bydureon
• SymlinPen
• Saxenda (Liraglutide)
• Tanzeum (Abliglutide)
• Trulicity (Dulaglutide)
• Victoza (Liraglutide)
• Parathyroid Hormone
• Forteo Pen
• Preotact/Preos
• Natpara
• Reproductive Hormones
• Follistim/Puregon Pen
• Gonal-f
• Wearable Devices - Product Analysis and Assessments
• Libertas (Becton Dickinson)
• Patch Pump (Sensile Medical)
• SmartDose (West Pharmaceuticals)
• Neulasta OnPro Injector (Insulet/Amgen)
• YpsoDose (Ypsomed)
• Electronic Semi-disposable
• E3D Patch Pump (Elcam)
• Mechanical Disposable
• enFuse (Enable Injections)
• Captive Devices
• sc2Wear Infusor (scPharmaceuticals)
• PatchPump (SteadyMed)
• Wireless Data
• Key Therapeutic Sector Analysis
• Anaphylaxis/Countermeasures
• Autoimmune Diseases
• Rheumatoid Arthritis
• Psoriasis
• Multiple Sclerosis
• Exenatide (Byetta)
• Bydureon
• Pramlinitide (Symlin)
• Abliglutide (Tanzeum)
• Hepatitis
• Hormones
• Osteoporosis
• Market Factors
• Regulatory Issues
• Device Branding
• Patient Adherence and Ease of Use
• Healthcare Economics
• Company Profiles